COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say

COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say The comments were made in documents posted ahead of Thursday's meeting of a panel of FDA's independent experts, who are expected to make recommendations on what strain an updated COVID-19 booster should target. https://ift.tt/inJrgdT

Comments

Popular posts from this blog

SC transfers PIL seeking implementation of law on mental health care to NHRC

Hospital-insurer conflict: Will latest circular by NMC help in reducing the pain of health insurance policyholders?

Over 9.19 crore hospital admissions facilitated under Ayushman Bharat since 2018